Levamisole activates several innate immune factors in Scophthalmus maximus (L.) (Teleostei)

Levamisole, originally synthesized as an anti-helminthic, has been widely used in human and veterinary medicine as an immunomodulator or adjuvant. However, data on its use in fish are scarce, and no information is available for turbot. To study the effects of levamisole treatment on the innate immun...

Full description

Bibliographic Details
Published in:International Journal of Immunopathology and Pharmacology
Main Authors: Álvarez-Pellitero, Mª del Pilar, Sitjà-Bobadilla, Ariadna, Bermúdez, Roberto, Quiroga, María Isabel
Other Authors: Ministerio de Ciencia y Tecnología (España), Stolt Sea Farm, Ministerio de Educación y Ciencia (España)
Format: Article in Journal/Newspaper
Language:unknown
Published: Sage Publications 2006
Subjects:
Online Access:http://hdl.handle.net/10261/253732
https://doi.org/10.1177/039463200601900403
https://doi.org/10.13039/501100006280
id ftcsic:oai:digital.csic.es:10261/253732
record_format openpolar
spelling ftcsic:oai:digital.csic.es:10261/253732 2024-02-11T10:08:28+01:00 Levamisole activates several innate immune factors in Scophthalmus maximus (L.) (Teleostei) Álvarez-Pellitero, Mª del Pilar Sitjà-Bobadilla, Ariadna Bermúdez, Roberto Quiroga, María Isabel Ministerio de Ciencia y Tecnología (España) Stolt Sea Farm Ministerio de Educación y Ciencia (España) 2006-10 http://hdl.handle.net/10261/253732 https://doi.org/10.1177/039463200601900403 https://doi.org/10.13039/501100006280 unknown Sage Publications http://dx.doi.org/10.1177/039463200601900403 Sí doi:10.1177/039463200601900403 issn: 0394-6320 e-issn: 2058-7384 International Journal of Immunopathology and Pharmacology 19(4): 727-738 (2006) http://hdl.handle.net/10261/253732 http://dx.doi.org/10.13039/501100006280 none Fish Immune response Immunomodulation Levamisole Psetta Scophthalmus Turbot artículo http://purl.org/coar/resource_type/c_6501 2006 ftcsic https://doi.org/10.1177/03946320060190040310.13039/501100006280 2024-01-16T11:15:14Z Levamisole, originally synthesized as an anti-helminthic, has been widely used in human and veterinary medicine as an immunomodulator or adjuvant. However, data on its use in fish are scarce, and no information is available for turbot. To study the effects of levamisole treatment on the innate immune system of juvenile turbot, two different doses (D1=500 mg/kg; D2=250 mg/kg dry food) were orally administered for 2 weeks and samplings were performed at -10, 14, 28, 49 and 77 days post treatment (p.t.). Biometrical, haematological, histological and immunological data were obtained. Specific growth rate was higher in the medicated groups than in the control (C), but the difference was statistically significant only for Dl fish at day 49 p.t. The leucocytes/trombocytes ratio was significantly higher in D1 than in C fish at 14 days p.t., but decreased subsequently. At most samplings, the percentage of the circulating lymphocytes was lower and that of the progranulocytes was higher in the medicated fish than in the C ones. The percentage of fish with high haemotopoietic activity in the kidney was clearly higher in D1 and D2 fish than in C ones at some sampling points. The respiratory burst activity of blood leucocytes was significantly higher in D1 fish than in C ones in all samplings, except at day 77 p.t. when control fish experienced a rebound effect. In all medicated fish, an initial increase of such activity was observed, followed by a further decrease. Their serum peroxidases followed a contrary pattern, with a decrease in the second sampling and a subsequent and non-significant recovery, a situation also observed for serum lysozyme and complement. Therefore, oral levamisole treatment actually affects some turbot immune factors, although stimulation or depression can occur depending on the considered factor and the administered dose. These results point out the interest of further studies on the mechanisms involved in the levamisole action for its adequate use as immunomodulator. Funding for this work was ... Article in Journal/Newspaper Scophthalmus maximus Turbot Digital.CSIC (Spanish National Research Council) International Journal of Immunopathology and Pharmacology 19 4 727 738
institution Open Polar
collection Digital.CSIC (Spanish National Research Council)
op_collection_id ftcsic
language unknown
topic Fish
Immune response
Immunomodulation
Levamisole
Psetta
Scophthalmus
Turbot
spellingShingle Fish
Immune response
Immunomodulation
Levamisole
Psetta
Scophthalmus
Turbot
Álvarez-Pellitero, Mª del Pilar
Sitjà-Bobadilla, Ariadna
Bermúdez, Roberto
Quiroga, María Isabel
Levamisole activates several innate immune factors in Scophthalmus maximus (L.) (Teleostei)
topic_facet Fish
Immune response
Immunomodulation
Levamisole
Psetta
Scophthalmus
Turbot
description Levamisole, originally synthesized as an anti-helminthic, has been widely used in human and veterinary medicine as an immunomodulator or adjuvant. However, data on its use in fish are scarce, and no information is available for turbot. To study the effects of levamisole treatment on the innate immune system of juvenile turbot, two different doses (D1=500 mg/kg; D2=250 mg/kg dry food) were orally administered for 2 weeks and samplings were performed at -10, 14, 28, 49 and 77 days post treatment (p.t.). Biometrical, haematological, histological and immunological data were obtained. Specific growth rate was higher in the medicated groups than in the control (C), but the difference was statistically significant only for Dl fish at day 49 p.t. The leucocytes/trombocytes ratio was significantly higher in D1 than in C fish at 14 days p.t., but decreased subsequently. At most samplings, the percentage of the circulating lymphocytes was lower and that of the progranulocytes was higher in the medicated fish than in the C ones. The percentage of fish with high haemotopoietic activity in the kidney was clearly higher in D1 and D2 fish than in C ones at some sampling points. The respiratory burst activity of blood leucocytes was significantly higher in D1 fish than in C ones in all samplings, except at day 77 p.t. when control fish experienced a rebound effect. In all medicated fish, an initial increase of such activity was observed, followed by a further decrease. Their serum peroxidases followed a contrary pattern, with a decrease in the second sampling and a subsequent and non-significant recovery, a situation also observed for serum lysozyme and complement. Therefore, oral levamisole treatment actually affects some turbot immune factors, although stimulation or depression can occur depending on the considered factor and the administered dose. These results point out the interest of further studies on the mechanisms involved in the levamisole action for its adequate use as immunomodulator. Funding for this work was ...
author2 Ministerio de Ciencia y Tecnología (España)
Stolt Sea Farm
Ministerio de Educación y Ciencia (España)
format Article in Journal/Newspaper
author Álvarez-Pellitero, Mª del Pilar
Sitjà-Bobadilla, Ariadna
Bermúdez, Roberto
Quiroga, María Isabel
author_facet Álvarez-Pellitero, Mª del Pilar
Sitjà-Bobadilla, Ariadna
Bermúdez, Roberto
Quiroga, María Isabel
author_sort Álvarez-Pellitero, Mª del Pilar
title Levamisole activates several innate immune factors in Scophthalmus maximus (L.) (Teleostei)
title_short Levamisole activates several innate immune factors in Scophthalmus maximus (L.) (Teleostei)
title_full Levamisole activates several innate immune factors in Scophthalmus maximus (L.) (Teleostei)
title_fullStr Levamisole activates several innate immune factors in Scophthalmus maximus (L.) (Teleostei)
title_full_unstemmed Levamisole activates several innate immune factors in Scophthalmus maximus (L.) (Teleostei)
title_sort levamisole activates several innate immune factors in scophthalmus maximus (l.) (teleostei)
publisher Sage Publications
publishDate 2006
url http://hdl.handle.net/10261/253732
https://doi.org/10.1177/039463200601900403
https://doi.org/10.13039/501100006280
genre Scophthalmus maximus
Turbot
genre_facet Scophthalmus maximus
Turbot
op_relation http://dx.doi.org/10.1177/039463200601900403

doi:10.1177/039463200601900403
issn: 0394-6320
e-issn: 2058-7384
International Journal of Immunopathology and Pharmacology 19(4): 727-738 (2006)
http://hdl.handle.net/10261/253732
http://dx.doi.org/10.13039/501100006280
op_rights none
op_doi https://doi.org/10.1177/03946320060190040310.13039/501100006280
container_title International Journal of Immunopathology and Pharmacology
container_volume 19
container_issue 4
container_start_page 727
op_container_end_page 738
_version_ 1790607809697546240